ArticleJournal of thoracic disease2018

Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189.

Sheenu Sheela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.